TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020
Revenue 231.91 Million 252.72 Million 160.88 Million 118.57 Million
Cost of Revenue 154.08 Million 148.67 Million 106.83 Million 83.99 Million
Gross Profit 77.82 Million 104.04 Million 54.04 Million 34.57 Million
Operating Expenses 77.82 Million 70.28 Million 48.04 Million 34.26 Million
Selling, General and Administrative Expenses 46.03 Million 36.62 Million 22.07 Million -
Research and Development Expenses 36.24 Million 33.66 Million 25.96 Million 21.01 Million
Other Expenses -4.45 Million 464 Thousand 967 Thousand 142 Thousand
Cost and Expenses 231.91 Million 218.95 Million 154.87 Million 118.26 Million
Operating Income -4.45 Million 38.15 Million 6 Million 311 Thousand
Interest Expense 602 Thousand 647 Thousand 306 Thousand 357 Thousand
Income Tax Expense -135 Thousand 3.01 Million 886 Thousand 38 Thousand
Earnings before Tax 4.77 Million 30.71 Million 7 Million 334 Thousand
Net Income 4.9 Million 27.69 Million 6.12 Million 296 Thousand
Earnings Per Share Basic 0.17 0.97 0.47 0.01
Earnings Per Share Diluted 0.14 0.95 0.46 0.01
Weighted Average Shares Outstanding 28.65 Million 28.65 Million 12.96 Million 34.79 Million
Weighted Average Shares Outstanding (Diluted) 34.79 Million 34.79 Million 13.17 Million 34.79 Million
Gross Margin 0.34 0.41 0.34 0.29
EBIT Margin 0.28 0.30 0.20 0.22
Profit Margin 0.02 0.11 0.04 0.00
EBITDA 64.15 Million 68.33 Million 32.75 Million 25.9 Million
Earnings Before Tax Margin -0.02 0.15 0.04 0.00

Income Statement Charts